Aurinia’s New CEO, Richard Glickman, to Present at Leerink Partners 6th Annual Global Healthcare Conference
February 10 2017 - 01:44PM
Business Wire
Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today
announced that its newly appointed Chief Executive Officer, Richard
M. Glickman and Celia Economides, Associate Vice President,
Investor Relations will participate in a Fireside Chat at the
Leerink Partners 6th Annual Global Healthcare Conference on
February 16th at 11:30am ET. A webcast will be available and can be
accessed via the investor section of the Aurinia website,
www.auriniapharma.com. A replay will also be archived on the site
following the event.
About AuriniaAurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering
from serious diseases with a high unmet medical need. The company
is currently developing voclosporin, an investigational drug, for
the treatment of lupus nephritis (LN), an inflammation of the
kidney caused by Systemic Lupus Erythematosus (SLE) and represents
a serious progression of SLE. The company is headquartered in
Victoria, BC and focuses its development efforts globally.
www.auriniapharma.com.
We Seek Safe Harbor.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170210005554/en/
Investor & Media Contact:Aurinia Pharmaceuticals
Inc.Celia EconomidesHead of IR &
Communicationsceconomides@auriniapharma.com